Can Gene Therapy Reverse Age-Related Diseases?

A Healthcare Revolution is Taking Root

In 2019, VCapital hosted world-renowned geneticist Professor George Church for "The Future of Medicine." Church's research at Harvard Medical School is focused on eliminating many of our toughest age-related chronic illnesses, such as:

• heart disease
• osteoarthritis
• cancer
• neurogenerative diseases
• kidney disease
• diabetes

In 2021, biotech company Rejuvenate Bio (founded by George Church, Dan Oliver, and Noah Davidsohn) was added to the VCapital portfolio. This team is focused on treating aging and age-related diseases through novel gene therapies and epigenetic programming. Dr. Church stated in a recent interview that when you’re rejuvenating cells, you’re also boosting all their repair mechanisms. The challenge for the near future is using artificial intelligence to design “delivery shuttles” that carry gene therapy where you want it to go. If cells can be convinced to kick in their own repair factory by giving them a dose of youth-promoting genes, lots of damage from aging can be reversed.

Rejuvenate Bio has made significant strides in validating its technology with multi-year trials in animals and capitalizing financially from interest from the animal health sector. With human trials on the horizon, a healthcare revolution is taking root. Their research holds the potential for a future where age-related diseases are addressed to increase the healthy lifespan of humans. Please join us on Thursday, May 2 at 3:00 pm Central Time for an enlightening conversation with George Church, Rejuvenate Bio leaders Dan Oliver and Noah Davidsohn, and VCapital’s Jim Vaughan about Rejuvenate Bio's progress in this exciting field of epigenetic programming.